Scientists have engineered yeast to transform one of humanity’s most abundant waste products into a high-value biomaterial worth more than $80 per kilogram.
The new “osteoyeast” platform converts human urine into hydroxyapatite—the calcium phosphate mineral that forms bones and teeth—offering both environmental and economic benefits for waste management systems worldwide.
Researchers from Lawrence Berkeley National Laboratory, UC Irvine, and the University of Illinois developed the synthetic biology approach by modifying Saccharomyces boulardii, a hardy yeast species that naturally stores minerals in specialized cellular compartments called vacuoles.
Mimicking Nature’s Bone Builders
The breakthrough came from observing how osteoblasts—the cells responsible for bone formation in animals—create hydroxyapatite through a complex multi-step process. These specialized cells accumulate calcium and phosphate in acidic compartments, then package the materials into vesicles that crystallize into bone mineral.
“The serendipitous part is this yeast already had similar molecular mechanisms,” said Yasuo Yoshikuni, head of the DNA Synthesis Science Program at the Joint Genome Institute. “Just mild tweaking was sufficient to convert the yeast into a cell factory for hydroxyapatite.”
The engineering required adding only two genes: one for a urea-breaking enzyme and another for a urea transporter. When the yeast breaks down urea from urine, it raises the pH inside cells, triggering a calcium pump that floods the vacuoles with mineral-forming ingredients.
Cellular Assembly Line
Using advanced microscopy techniques, the research team tracked exactly how osteoyeast manufactures hydroxyapatite. The process begins when calcium and phosphate accumulate as amorphous particles inside acidic vacuoles, stabilized by naturally occurring polyphosphate molecules.
Next, these mineral-loaded vacuoles transform into extracellular vesicles that get secreted from the cells. Once outside, the vesicles can merge together while enzymes break down the stabilizing polyphosphate. This triggers crystallization of the amorphous material into platelike hydroxyapatite crystals.
Remarkably, this crystallization occurs at relatively low pH levels around 5.2—much lower than the highly alkaline conditions typically required for synthetic hydroxyapatite production. The researchers suspect that proteins secreted alongside the mineral vesicles act as templates, similar to how collagen guides bone formation in vertebrates.
Turning Waste Into Wealth
The technology addresses a pressing challenge in wastewater management. Although urine represents just 1% of total wastewater volume, it contains 70-90% of nitrogen and 50-65% of phosphorus in waste streams—nutrients that cause environmental problems like eutrophication when released into waterways.
Current urine recycling efforts focus on producing low-value fertilizers worth $300-400 per ton. But hydroxyapatite commands premium prices exceeding $80 per kilogram due to its use in orthopedic surgery, dental applications, and water purification systems.
The osteoyeast platform achieved production rates exceeding 1 gram of hydroxyapatite per liter of urine. Economic modeling for a San Francisco-sized city shows the process could generate approximately $1.4 million in annual profits while significantly reducing wastewater treatment costs.
Key Production Advantages
The biological approach offers several advantages over conventional hydroxyapatite manufacturing:
- Uses existing phosphorus and urea in fresh urine rather than requiring chemical inputs
- Operates under mild reaction conditions suitable for distributed applications
- Produces high-selectivity hydroxyapatite that’s relatively insensitive to reaction variations
- Generates both bone material and nitrogen-rich fertilizer from the same feedstock
Beyond Bone Building
The research team envisions expanding applications beyond hydroxyapatite production. The same engineering principles could enable yeast to manufacture other biominerals or selectively extract valuable elements from waste streams for environmentally friendly bio-mining operations.
“Today, we use about 1% of the world’s energy to make fertilizers from nitrogen gas,” Yoshikuni explained. “If we’re able to produce both hydroxyapatite and make nitrogen fertilizer from the ammonia, we could potentially replace a significant portion of total demand of nitrogen; saving energy while also dramatically reducing the costs at wastewater facilities.”
The patented osteoyeast technology is now available for licensing, potentially opening new pathways for sustainable biomaterial production from human waste streams.
If our reporting has informed or inspired you, please consider making a donation. Every contribution, no matter the size, empowers us to continue delivering accurate, engaging, and trustworthy science and medical news. Independent journalism requires time, effort, and resources—your support ensures we can keep uncovering the stories that matter most to you.
Join us in making knowledge accessible and impactful. Thank you for standing with us!